Daniel Peeper
@d_peeper
Cancer researcher @NKI_nl and @oncodeinstitute, Cofounder of Flindr Tx, Developing rational cancer & immune cell combination treatments, Runner
ID: 2734952884
06-08-2014 09:55:32
66 Tweet
675 Followers
254 Following
Researchers from Daniel Peeper's NKI research group discovered an unexpected effect of epacadostat, a new type of immunotherapy that inhibits the IDO1 protein. This may explain why this therapy proved ineffective in the final phase of clinical research ➡️ bit.ly/3ZcXrge
Several exciting vacancies (incl. European Research Council (ERC) Adv. grant) in my lab at the The Netherlands Cancer Institute for ambitious postdocs with expertise in immunology and an interest in translational cancer research. More info and applications: nki.nl/research/resea… #postdocjobs #immunotherapy
Excited to launch the second conference by The Netherlands Cancer Institute and Weizmann Institute on the latest developments in cancer research. Great speaker lineup and exciting data!
The research group headed by Daniel Peeper at The Netherlands Cancer Institute & Oncode Institute can get started on their research into a strategy to help future cancer patients benefit more from immunotherapy. Thanks to KWFKankerbestrijding! In focus: TWEAK-Fn14 signaling in tumor cells.
We’re hiring! 🔬3 exciting positions open for talented #postdocs interested in #ImmunotherapyResistance in #cancer. The Daniel Peeper lab is at the comprehensive The Netherlands Cancer Institute, using advanced techniques to improve #Immunotherapy. Join us: nki.nl/research/resea… #PostdocJobs #Immunology
Congrats to my postdoc Johanna Veldman for obtaining a prestigious NWO Funding Veni fellowship to improve cancer immunotherapy!
Congrats to the 4 lead investigators Chun-Pu, Pierre, Astrid and Georgi from my lab The Netherlands Cancer Institute Oncode Institute + collaborators, reporting today in Cancer Cell several genes whose inactivation generates fitter immune T cells for enhanced tumor killing. cell.com/cancer-cell/fu…
Happy to share a Nature Reviews Cancer / Nature Rev Immunol poster by Daniela Thommen & myself, showing new therapeutic approaches that are combined with PD1 blockade for synergistic clinical benefit, using mechanistic understanding of cancer–immune interactions rdcu.be/dPp2z